A new study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Center has demonstrated a new, non-invasive imaging technique can accurately detect clear-cell renal cell carcinoma, ...
"Imaging using [⁸⁹Zr]Zr-girentuximab has the potential to change clinical practice in renal cell carcinoma," write the study authors. HealthDay News — ⁸⁹Zr-labeled monoclonal antibody ...
For patients with stage T1a renal cell carcinoma (T1a RCC), ablation seems to be as effective as resection or nephrectomy, according to a study published online March 3 in Radiology. Johanne ...
A large national study in Denmark following nearly 1,900 patients over almost a decade found that a minimally invasive ...
According to a new study, ablation for small renal tumors showed similar risk for tumor progression, as well as fewer ...
A large national study in Denmark following nearly 1,900 patients over almost a decade has found that a minimally invasive ...
Stage 3 RCC involves tumor growth beyond the kidney, affecting nearby tissues or lymph nodes, but not distant organs. Diagnosis includes imaging, biopsy, and molecular testing to guide treatment ...
HIF family transcription factor expression in a cohort of 4362 patients with renal cell carcinoma (RCC). Stratification of the intermediate IMDC risk group according to baseline radiological tumor ...
In a recent study, mean sensitivity was 85.5% and specificity 87% for detection of clear-cell renal cell carcinoma. (HealthDay News) — ⁸⁹Zr-labeled monoclonal antibody ([⁸⁹Zr]Zr-girentuximab) for ...
Locally advanced ccRCC at stage III typically reflects T3 invasion into renal vein/IVC or perinephric fat, with optional N1 regional lymph node involvement, without distant metastases. Definitive risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results